ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,939 | +41.5% | 146,495 | +99.0% | 0.03% | +112.5% |
| Q2 2023 | $2,077 | -99.7% | 73,634 | +154.9% | 0.02% | +77.8% |
| Q2 2022 | $812,000 | +78.9% | 28,886 | +193.7% | 0.01% | +200.0% |
| Q1 2022 | $454,000 | -72.3% | 9,834 | -49.5% | 0.00% | -66.7% |
| Q4 2021 | $1,638,000 | +31.4% | 19,484 | +4.1% | 0.01% | +50.0% |
| Q3 2021 | $1,247,000 | +106.1% | 18,711 | +64.6% | 0.01% | +100.0% |
| Q2 2021 | $605,000 | -9.0% | 11,365 | -25.9% | 0.00% | 0.0% |
| Q1 2021 | $665,000 | +62.2% | 15,331 | +94.0% | 0.00% | +50.0% |
| Q4 2020 | $410,000 | -75.6% | 7,902 | -84.6% | 0.00% | -81.8% |
| Q3 2020 | $1,681,000 | +524.9% | 51,422 | +818.7% | 0.01% | +450.0% |
| Q2 2020 | $269,000 | – | 5,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |